377 related articles for article (PubMed ID: 37178431)
1. Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus.
Huang M; Chen W; Wang M; Huang Y; Liu H; Ming Y; Chen Y; Tang Z; Jia B
BioDrugs; 2023 May; 37(3):331-352. PubMed ID: 37178431
[TBL] [Abstract][Full Text] [Related]
2. Diabetes type 1: Can it be treated as an autoimmune disorder?
Vallianou NG; Stratigou T; Geladari E; Tessier CM; Mantzoros CS; Dalamaga M
Rev Endocr Metab Disord; 2021 Dec; 22(4):859-876. PubMed ID: 33730229
[TBL] [Abstract][Full Text] [Related]
3. Advances in immunotherapy of type I diabetes.
Ni Q; Pham NB; Meng WS; Zhu G; Chen X
Adv Drug Deliv Rev; 2019 Jan; 139():83-91. PubMed ID: 30528629
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview.
Rapini N; Schiaffini R; Fierabracci A
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204344
[TBL] [Abstract][Full Text] [Related]
5. Delivery technologies for cancer immunotherapy.
Riley RS; June CH; Langer R; Mitchell MJ
Nat Rev Drug Discov; 2019 Mar; 18(3):175-196. PubMed ID: 30622344
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific immunotherapies in type 1 diabetes.
Zhang X; Dong Y; Liu D; Yang L; Xu J; Wang Q
J Trace Elem Med Biol; 2022 Sep; 73():127040. PubMed ID: 35868165
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapies currently in development for the treatment of type 1 diabetes.
Davis IC; Randell J; Davis SN
Expert Opin Investig Drugs; 2015; 24(10):1331-41. PubMed ID: 26364507
[TBL] [Abstract][Full Text] [Related]
8. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
[TBL] [Abstract][Full Text] [Related]
9. Combination immunotherapies for type 1 diabetes mellitus.
Pozzilli P; Maddaloni E; Buzzetti R
Nat Rev Endocrinol; 2015 May; 11(5):289-97. PubMed ID: 25688000
[TBL] [Abstract][Full Text] [Related]
10. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
11. Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
Chatenoud L
Nat Rev Endocrinol; 2010 Mar; 6(3):149-57. PubMed ID: 20173776
[TBL] [Abstract][Full Text] [Related]
12. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Immune-Based Therapies for Type 1 Diabetes.
Smigoc Schweiger D
Horm Res Paediatr; 2023; 96(6):631-645. PubMed ID: 35533645
[TBL] [Abstract][Full Text] [Related]
14. Progress in the development of immune-based therapies for type 1 diabetes mellitus.
von Herrath M; Rottembourg D; Bresson D
BioDrugs; 2006; 20(6):341-50. PubMed ID: 17176121
[TBL] [Abstract][Full Text] [Related]
15. Teplizumab: type 1 diabetes mellitus preventable?
Misra S; Shukla AK
Eur J Clin Pharmacol; 2023 May; 79(5):609-616. PubMed ID: 37004543
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes mellitus.
Katsarou A; Gudbjörnsdottir S; Rawshani A; Dabelea D; Bonifacio E; Anderson BJ; Jacobsen LM; Schatz DA; Lernmark Å
Nat Rev Dis Primers; 2017 Mar; 3():17016. PubMed ID: 28358037
[TBL] [Abstract][Full Text] [Related]
17. Consensus evidence-based guidelines for insulin therapy in patients with type 1 diabetes mellitus as per Indian clinical practice.
Kanungo A; Jhingan A; Sahay RK; Muruganathan A; Das AK;
J Assoc Physicians India; 2014 Jul; 62(7 Suppl):26-33. PubMed ID: 25668934
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy and type 1 diabetes mellitus.
Chellappan DK; Sivam NS; Teoh KX; Leong WP; Fui TZ; Chooi K; Khoo N; Yi FJ; Chellian J; Cheng LL; Dahiya R; Gupta G; Singhvi G; Nammi S; Hansbro PM; Dua K
Biomed Pharmacother; 2018 Dec; 108():1188-1200. PubMed ID: 30372820
[TBL] [Abstract][Full Text] [Related]
19. Potential role of TRAIL in the management of autoimmune diabetes mellitus.
Bernardi S; Norcio A; Toffoli B; Zauli G; Secchiero P
Curr Pharm Des; 2012; 18(35):5759-65. PubMed ID: 22726118
[TBL] [Abstract][Full Text] [Related]
20. Regulatory and policy issues for T1DM immunotherapy.
Fleming A
Hum Vaccin; 2011 Jan; 7(1):50-5. PubMed ID: 21242726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
